Publication dates

All regions

Anti-infective Industry, November 2014 Market Reports from Top Publishers

You might be interested in: Therapeutics, Medical Equipment, Anti-infective Drug, more »


 
1-20 of about 1 300 reports for Anti-infective

Anti-Infective Drug News 24 NOVEMBER 2014

Anti-Infective Drug News 24 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - AbbVie To Put Pressure On Gilead With Prospective HCV Approval Industry Brief - Pfizer's Trumenba Available In US Industry Brief - RedHill's RHB-105 Gains FDA QIDP Designation ...

Ambalal Sarabhai Enterprises Limited (Symbol:500009) SWOT Analysis, Strategy, Revenues and Profits

Ambalal Sarabhai Enterprises Limited (Symbol:500009) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Research and development center which is engaged in the development of new drugs according to the market requirement. Its product portfolio includes analgesic, anti-inflammatory, anti-infective, nutritional ...

GuiZhou YiBai Pharmaceutical Co., Ltd. (Symbol:600594) SWOT Analysis, Strategy, Revenues and Profits

GuiZhou YiBai Pharmaceutical Co., Ltd. (Symbol:600594) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... System drugs, pediatric, gynecological medicine, andrological medication, anti-infective drugs, anti-inflammatory analgesics, replenishing drugs, and other drugs. The company's cardiovascular drug liqi ...

PT Darya-Varia Laboratoria Tbk (Symbol:DVLA) SWOT Analysis, Strategy, Revenues and Profits

PT Darya-Varia Laboratoria Tbk (Symbol:DVLA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Of anti asthma, anti infective, cardio, central nervous system, cough cold, derma, endometabolic, eye and ear prep, gastro instestinal, somatic, vitamins and minerals, and women's health. It partners ...

TTY Biopharm Company Limited (Symbol:4105) SWOT Analysis, Strategy, Revenues and Profits

TTY Biopharm Company Limited (Symbol:4105) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Development and marketing of drugs for cancer, anti-infection and blood vessel diseases. The company's oncology product portfolio includes ts-1, ufur, irino, gemmis, epicin, oxalip, asadin, thado, tyxan, anazo ...

Dawnrays Pharmaceutical (Symbol:Holdings) SWOT Analysis, Strategy, Revenues and Profits

Dawnrays Pharmaceutical (Symbol:Holdings) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Kwang Dong Pharmaceutical Co., Ltd. (Symbol:009290) SWOT Analysis, Strategy, Revenues and Profits

Kwang Dong Pharmaceutical Co., Ltd. (Symbol:009290) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Injection, ridbon tab., Poweracen, and aldocept tab., Among others. Its products find application in the therapeutic areas of gastrointestinal, cardiovascular, respiratory system, central nervous system, anti-infectives ...

Creative Antibiotics Sweden AB - Strategic SWOT Analysis Review

Creative Antibiotics Sweden AB - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Creative antibiotics sweden ab - strategic swot analysis review summarycreative antibiotics sweden ab (creative antibiotics) is a biotechnology company. The company develops anti-infective ...

Henan Topfond Pharmaceutical Co., Ltd. (600253) - Financial and Strategic SWOT Analysis Review

Henan Topfond Pharmaceutical Co., Ltd. (600253) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Ingredients, intermediates, and western and chinese trional finished dosage forms. The company offers anti infective, anti-aids, anti prostate, anti diabetes, anti allergic, anti osteoporosis, anti ...

Korea United Pharm, Inc. (Symbol:033270) SWOT Analysis, Strategy, Revenues and Profits

Korea United Pharm, Inc. (Symbol:033270) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Metabolic, anti-infectives, allergy & immune, obstetrical & gynecological agents vitamins & minerals & nutrition and anticancer. Some of the products offered under this segment include alphacolin, tefudex ...

About 700 reports for Anti-infective

Download Unlimited Documents from Trusted Public Sources

Hospital Industry in China

  • June 2013 Report
  • June 2013
    44 pages
  • Hospital  

  • China  

View report >

3 Companies for Anti-infective

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Icon Group

United States

Johnson and Johnson

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.